University Of Oxford Study Supports Use Of Vaxzevria As Third Dose Against Omicron
AstraZeneca's Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant following a third dose booster, according to data from a new laboratory study. Neutralisation titres for Omicron were boosted following a third dose with Vaxzevria compared to titres after a second dose. The levels seen after the third…
bubmagDecember 23, 2021